Mor E - Search Results

1

Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management.

Gurevich M, Levi I, Steinberg R, Shonfeld T, Shapiro R, Israeli M, Sprecher H, Shalit I, Mor E. Gurevich M, et al. Among authors: mor e. Transpl Infect Dis. 2012 Oct;14(5):E97-101. doi: 10.1111/j.1399-3062.2012.00776.x. Epub 2012 Aug 16. Transpl Infect Dis. 2012. PMID: 22897560

2

ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients.

Israeli M, Klein T, Sredni B, Avitzur Y, Mor E, Bar-Nathen N, Steinberg R, Dinari G, Shapiro R. Israeli M, et al. Among authors: mor e. Liver Transpl. 2008 Jun;14(6):893-8. doi: 10.1002/lt.21426. Liver Transpl. 2008. PMID: 18508374 Free article.

3

Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform.

Israeli M, Yussim A, Mor E, Sredni B, Klein T. Israeli M, et al. Among authors: mor e. Transpl Immunol. 2007 Jul;18(1):7-12. doi: 10.1016/j.trim.2007.03.005. Epub 2007 Apr 9. Transpl Immunol. 2007. PMID: 17584596

4

The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation.

Lapidus-Krol E, Shapiro R, Amir J, Davidovits M, Steinberg R, Mor E, Avitzur Y. Lapidus-Krol E, et al. Among authors: mor e. Pediatr Transplant. 2010 Sep 1;14(6):753-60. doi: 10.1111/j.1399-3046.2010.01330.x. Epub 2010 May 3. Pediatr Transplant. 2010. PMID: 20477976

5

Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 children.

Shapiro R, Weismann I, Mandel H, Eisenstein B, Ben-Ari Z, Bar-Nathan N, Zehavi I, Dinari G, Mor E. Shapiro R, et al. Among authors: mor e. Transplantation. 2001 Aug 15;72(3):428-32. doi: 10.1097/00007890-200108150-00012. Transplantation. 2001. PMID: 11502971

6

Antibody response to influenza vaccine in pediatric liver transplant recipients.

Hojsak I, Avitzur Y, Mor E, Shamir R, Haimi-Cohen Y, Zakay-Rones Z, Wolf D, Shapiro R. Hojsak I, et al. Among authors: mor e. Pediatr Infect Dis J. 2011 Jun;30(6):491-4. doi: 10.1097/INF.0b013e31820b7c22. Pediatr Infect Dis J. 2011. PMID: 21248658

7

The immune-modulator AS101 reduces anti-HLA antibodies in sera of sensitized patients: a structural approach.

Israeli M, Sredni B, Mor E, Zakai C, Tadmor B, Klein T. Israeli M, et al. Among authors: mor e. Int Immunopharmacol. 2012 Aug;13(4):483-9. doi: 10.1016/j.intimp.2012.05.019. Epub 2012 Jun 7. Int Immunopharmacol. 2012. PMID: 22683182

8

Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.

Ben-Ari Z, Mor E, Shaharabani E, Bar-Nathan N, Shapira Z, Tur-Kaspa R. Ben-Ari Z, et al. Among authors: mor e. Transplant Proc. 2000 Jun;32(4):709-10. doi: 10.1016/s0041-1345(00)00951-9. Transplant Proc. 2000. PMID: 10856553 No abstract available.

9

Defibrotide for the treatment of veno-occlusive disease after liver transplantation.

Mor E, Pappo O, Bar-Nathan N, Shaharabani E, Shapira Z, Tur-Kaspa R, Ben-Ari Z. Mor E, et al. Transplantation. 2001 Oct 15;72(7):1237-40. doi: 10.1097/00007890-200110150-00009. Transplantation. 2001. PMID: 11602848

10

Long-term Outcome of 1-step Kidney Transplantation and Bladder Augmentation Procedure in Pediatric Patients.

Cleper R, Ben Meir D, Krause I, Livne P, Mor E, Davidovits M, Dagan A. Cleper R, et al. Among authors: mor e. Transplantation. 2018 Jun;102(6):1014-1022. doi: 10.1097/TP.0000000000002050. Transplantation. 2018. PMID: 29319624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters